Warming Effect on Miriplatin–Lipiodol Suspension as a Chemotherapeutic Agent for Transarterial Chemoembolization for Hepatocellular Carcinoma: Preliminary Clinical Experience

被引:0
|
作者
Shinn-ichi Kora
Hiroshi Urakawa
Toshimichi Mitsufuji
Akinobu Osame
Hideyuki Higashihara
Kengo Yoshimitsu
机构
[1] Fukuoka University,Department of Radiology, Faculty of Medicine
[2] Fukuoka University Chikushi Hospital,Department of Radiology
关键词
Chemoembolization; Hepatocellular carcinoma; Miriplatin; Warming;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1023 / 1029
页数:6
相关论文
共 50 条
  • [1] Erratum to: Warming Effect on Miriplatin–Lipiodol Suspension as a Chemotherapeutic Agent for Transarterial Chemoembolization for Hepatocellular Carcinoma: Preliminary Clinical Experience
    Shinn-ichi Kora
    Hiroshi Urakawa
    Toshimichi Mitsufuji
    Akinobu Osame
    Hideyuki Higashihara
    Kengo Yoshimitsu
    CardioVascular and Interventional Radiology, 2013, 36 : 1722 - 1722
  • [2] Warming Effect on Miriplatin-Lipiodol Suspension as a Chemotherapeutic Agent for Transarterial Chemoembolization for Hepatocellular Carcinoma: Preliminary Clinical Experience
    Kora, Shinn-ichi
    Urakawa, Hiroshi
    Mitsufuji, Toshimichi
    Osame, Akinobu
    Higashihara, Hideyuki
    Yoshimitsu, Kengo
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2013, 36 (04) : 1023 - 1029
  • [3] Warming Effect on Miriplatin-Lipiodol Suspension as a Chemotherapeutic Agent for Transarterial Chemoembolization for Hepatocellular Carcinoma: Preliminary Clinical Experience (vol 36, pg 1023, 2013)
    Kora, Shinn-ichi
    Urakawa, Hiroshi
    Mitsufuji, Toshimichi
    Osame, Akinobu
    Higashihara, Hideyuki
    Yoshimitsu, Kengo
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2013, 36 (06) : 1722 - 1722
  • [4] Warming effect on miriplatin-lipiodol suspension for potential use as a chemotherapeutic agent for transarterial chemoembolization of hepatocellular carcinoma: In vitro study
    Kora, Shin-ichi
    Urakawa, Hiroshi
    Mitsufuji, Toshimichi
    Osame, Akinobu
    Higashihara, Hideyuki
    Ohki, Toshihiro
    Yoshimitsu, Kengo
    HEPATOLOGY RESEARCH, 2013, 43 (10) : 1100 - 1104
  • [5] Feasibility and Safety of Repeated Transarterial Chemoembolization Using Miriplatin-Lipiodol Suspension for Hepatocellular Carcinoma
    Matsumoto, Tomohiro
    Ichikawa, Hitoshi
    Imai, Jin
    Hayashi, Toshihiko
    Tomita, Kosuke
    Mine, Takahiko
    Kojima, Seiichiro
    Watanabe, Norihito
    Hasebe, Terumitsu
    ANTICANCER RESEARCH, 2017, 37 (06) : 3183 - 3187
  • [6] Safety and Short-term Therapeutic Effects of Miriplatin-Lipiodol Suspension in Transarterial Chemoembolization (TACE) for Hepatocellular Carcinoma
    Okabe, Kazutoshi
    Beppu, Toru
    Haraoka, Katsuki
    Oh-Uchida, Yoshihiro
    Yamamura, Sadahiro
    Tomiyasu, Shinjiro
    Yamanaka, Tsuyoshi
    Sano, Osamu
    Masuda, Toshiro
    Chikamoto, Akira
    Fujiyama, Shigetoshi
    Baba, Hideo
    ANTICANCER RESEARCH, 2011, 31 (09) : 2983 - 2988
  • [7] Which is the Best Chemotherapeutic Agent for Transarterial Chemoembolization of Hepatocellular Carcinoma?
    Boulin, Mathieu
    Guiu, Boris
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2016, 39 (06) : 953 - 954
  • [8] Which is the Best Chemotherapeutic Agent for Transarterial Chemoembolization of Hepatocellular Carcinoma?
    Mathieu Boulin
    Boris Guiu
    CardioVascular and Interventional Radiology, 2016, 39 : 953 - 954
  • [9] Reply: Which is the Best Chemotherapeutic Agent for Transarterial Chemoembolization of Hepatocellular Carcinoma?
    Favelier, Sylvain
    Pottecher, Pierre
    Estivalet, Louis
    Loffroy, Romaric
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2016, 39 (06) : 955 - 956
  • [10] Reply: Which is the Best Chemotherapeutic Agent for Transarterial Chemoembolization of Hepatocellular Carcinoma?
    Sylvain Favelier
    Pierre Pottecher
    Louis Estivalet
    Romaric Loffroy
    CardioVascular and Interventional Radiology, 2016, 39 : 955 - 956